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Abstract Myogenic differentiation involves myoblast
fusion and induction of muscle-speciﬁc gene expression,
which are both stimulated by pharmacological (LiCl),
genetic, or IGF-I-mediated GSK-3b inactivation. To assess
whether stimulation of myogenic differentiation is common
to ligand-mediated GSK-3b inactivation, myoblast fusion
and muscle-speciﬁc gene expression were investigated in
response to Wnt-3a. Moreover, crosstalk between IGF-I/
GSK-3b/NFATc3 and Wnt/GSK-3b/b-catenin signaling
was assessed. While both Wnt-3a and LiCl promoted
myoblast fusion, muscle-speciﬁc gene expression was
increased by LiCl, but not by Wnt-3a or b-catenin over-
expression. Furthermore, LiCl and IGF-I, but not Wnt-3a,
increased NFATc3 transcriptional activity. In contrast,
b-catenin-dependent transcriptional activity was increased
by Wnt-3a and LiCl, but not IGF-I. These results for the ﬁrst
time reveal a segregated regulation of myoblast fusion and
muscle-speciﬁc gene expression following stimulation of
myogenic differentiation in response to distinct ligand-
speciﬁc signaling routes of GSK-3b inactivation.
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Introduction
Satellite cells are muscle precursor cells located between
the basement and sarcolemmal membrane in skeletal
muscles [1]. These mononuclear cells are activated in
response to injury or recovery from atrophy, which is
required for efﬁcient regeneration and restoration of mus-
cle mass [2, 3]. Proliferating satellite cells are referred to as
myoblasts, which subsequently differentiate to fuse with
existing myoﬁbers or form new myoﬁbers [4]. In addition
to myoblast fusion, myogenic differentiation is character-
ized by increased transcriptional activity of the muscle
regulatory factors (MRFs), which promote expression of
muscle-speciﬁc genes. Examples of muscle-speciﬁc genes
are structural proteins of the contractile apparatus such as
troponin-I (TnI) and myosin heavy chain (MyHC), and
enzymes involved in muscle energy metabolism such as
muscle creatine kinase (MCK) [5].
Post-natal muscle growth is stimulated by insulin-like
growth factor-I (IGF-I), and IGF-I is known to promote
myogenic differentiation [6,7]. IGF-I induces an increase in
muscle-speciﬁc gene expression during myogenic differen-
tiation, which involves activation of Akt/PKB, hereafter
referred to as Akt, and inactivation of glycogen synthase
kinase-3b (GSK-3b)[ 8]. Genetic or pharmacological inac-
tivation of GSK-3b also promotes muscle-speciﬁc gene
expression and myotube fusion in differentiating myoblasts,
N. A. M. Pansters and J. L. J. van der Velden contributed equally to
this work.
Electronic supplementary material The online version of this
article (doi:10.1007/s00018-010-0467-7) contains supplementary
material, which is available to authorized users.
N. A. M. Pansters   J. L. J. van der Velden  
M. C. J. M. Kelders   A. M. W. J. Schols   R. C. J. Langen (&)
Department of Respiratory Medicine,
NUTRIM School for Nutrition, Toxicology and Metabolism,
Maastricht University Medical Centre,
PO Box 5800, 6202 AZ Maastricht, The Netherlands
e-mail: r.langen@pul.unimaas.nl
H. Laeremans
Department of Pharmacology and Toxicology,
NUTRIM School for Nutrition,
Toxicology and Metabolism, Maastricht University
Medical Centre, Maastricht, The Netherlands
Cell. Mol. Life Sci. (2011) 68:523–535
DOI 10.1007/s00018-010-0467-7 Cellular and Molecular Life Sciencessuggesting a central role for GSK-3b in myogenic differ-
entiation [9]. This notion is further supported by in vivo
evidence revealing that markers of muscle differentiation
and regeneration are inversely related to GSK-3b activity
during skeletal muscle regrowth [10]. Of note is that phar-
macological inhibition of GSK-3bactivitybylithium (LiCl)
has a more striking effect on myoblast fusion and myotube
formation than IGF-I [8], which could be related to the
ability of LiCl to mimic Wnt/b-catenin signaling [11, 12].
Wnt/b-catenin signaling in part depends on the inacti-
vation of GSK-3, which leads to an accumulation of the
transcriptional co-activator b-catenin [13, 14]. Under basal
conditions, b-catenin levels are regulated by a protein
complex containing Axin, adenomatous polyposis coli
(APC), GSK-3b, and Casein kinase 1a (CK1a), hereafter
termed the ‘degradation complex’. This degradation com-
plex N-terminally phosphorylates b-catenin [15] and
thereby labeling it for degradation by the ubiquitin–pro-
teasome pathway [16]. When Wnt ligands form a ternary
complex with membrane receptors Frizzled (Fz), a seven-
transmembrane protein, and the low-density lipoprotein
receptor-related protein 5/6 (LRP5/6) [17], Dishevelled
(Dvl) is activated. Activated Dvl recruits Axin from the
degradation complex to the membrane [18] preventing
GSK-3b from phosphorylating b-catenin, resulting in its
stabilization [19]. Cytoplasmic accumulated b-catenin is
involved in cell–cell interactions in complex with cadher-
ins [20, 21]. Increased nuclear concentrations of b-catenin
result in induction of growth-associated genes such as
c-myc and cyclin D1 by interacting with transcriptional
co-activators such as members of the T-cell factor/Lym-
phocyte-enhancement factor-1 (Tcf/Lef-1) family [22].
Wnt/b-catenin signaling is essential in embryogenesis
[23, 24] including muscle development, as Wnt ligands
regulate the speciﬁcation of skeletal myoblasts in the par-
axial mesoderm [25–27], and induce location-speciﬁc
expression of MRFs [28]. However, Wnt/b-catenin sig-
naling not only contributes to embryonic but also to post-
natal muscle formation, as it has been implicated in muscle
regeneration [29] and hypertrophy [30]. Recently, it has
been shown that Wnt’s 1, 3A, and 5A are expressed in
activated satellite cells. Moreover, ectopic exposure of
satellite cells to these Wnts enhanced proliferation [31],
while Wnt’s 4 and 6 reduced this process [31]. Conversely,
inhibition of Wnt signaling abrogated differentiation [32].
In this study, we evaluated the effects of Wnt/b-catenin
signaling induced by Wnt-3a on differentiating myoblasts.
We hypothesized that Wnt-3a would induce b-catenin
signaling, and promote myogenic differentiation in a sim-
ilar manner as observed following pharmacological
inhibition of GSK-3b. Improved understanding of the
processes regulating myogenic differentiation can be
applied to therapeutic approaches to stimulate effective
skeletal muscle regeneration following muscle trauma or
atrophy.
Materials and methods
Cell culture
The murine skeletal muscle cell line C2C12 (ATCC #
CRL1772) and the murine ﬁbroblast control L-cells (ATCC
# CRL2648) and Wnt-3a secreting L-cells (ATCC #
CRL2647) (LGC Promochem, Teddington, UK) were
cultured in growth medium (GM). This was composed of
low (for C2C12 cells) or high (for L-cells) glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
antibiotics (50 U/ml penicillin and 50 lg/ml streptomycin)
and 9% (v/v) fetal bovine serum (FBS) (all from Gibco,
Rockville, MD). Conditioned medium (CM) containing
Wnt-3a CM was obtained from Wnt-3a secreting L-cells
(or control-CM from control L-cells) by culturing them on
high-glucose DMEM containing 5% FBS without supple-
mentation of antibiotics for 7 days until approximately
reaching conﬂuency. Medium was collected after 4 and
7 days, pooled, spun down at 1,5009g for 3 min, ﬁlter
sterilized (20 lm) and frozen at -20C in aliquotes.
C2C12 cells were plated at 10
4 cm
2 and cultured in GM for
24 h. To induce spontaneous differentiation by growth
factor withdrawal [33], GM was replaced with differenti-
ation medium (DM), which contained low-glucose DMEM
with 1.0% heat-inactivated FBS and antibiotics. Alterna-
tively, differentiation was induced with conditioned
medium (CM) of control (control-CM) or Wnt-3a secreting
L-cells, diluted in DM. C2C12 cells were grown on
Matrigel (BD Biosciences, Bedford, MA)-coated (1:50 in
DMEM low glucose) dishes as described previously [34].
Murine IGF-I (Calbiochem, La Jolla, CA) or LiCl (Sigma,
St. Louis, MO) was added directly after induction of dif-
ferentiation and again 24 h later when the cells were
provided with fresh DM, and then every 48 h thereafter.
The anti-mouse Wnt-3a antibody (MAB1324, R&D
systems, Abingdon, UK) was used to neutralize Wnt-3a-
conditioned medium effects by incubated Wnt-3a-condi-
tioned medium with anti-Wnt-3a at 37C for 1 h prior to
dilution with DM and addition to the C2C12 cells.
Stable cell lines
For the assessment of b-catenin-assisted T-cell
factor/lymphocyte enhancer factor (TCF/LEF)-dependent
transcriptional activation, or the troponin I (TnI) promoter
activity during differentiation, stable C2C12 cell lines were
created carrying a genomic TCF/LEF promoter-luciferase
reporter gene [35] or a TnI promoter-luciferase reporter
524 N. A. M. Pansters et al.gene [36]. To determine luciferase activity, the cells were
lysed in luciferase lysis buffer (Promega, Madison, WI)
and stored at -80C. Prior to analysis, the lysates were
spun at 16,0009g and 4C, and the soluble fraction was
used. Luciferase activity was measured according to the
manufacturer’s instructions and expressed after correcting
for total protein in the soluble fraction. Total protein con-
centration was assessed by a Bio-Rad protein assay kit
(Bio-Rad, Hercules, CA) according to the manufacturer’s
instructions, R
2 values were[0.98 for the standard curve.
Transfections and plasmids
Transient transfections were performed using Nanofectin
(PAA, Pasching, Austria) and in all cases included
co-transfection with pSV-b-gal to correct for differences in
transfection efﬁciency (Promega, Madison, WI). According
to the manufacturer’s instructions, 1.0 lg plasmid per
3.2 ll nanofectin was used. Per transfection, 1.0–2.5 lg
DNA of expression plasmids or empty vector controls was
used per 35-mm dish. The transfection mix was added 6 h
prior to differentiation induction. TCF/LEF luciferase
reporter plasmid was used to measure b-catenin-dependent
transcriptional activity, the troponin I (TnI)-luciferase
plasmid was used as a reporter for the activity of muscle-
speciﬁc transcription factors and the 4RTK [37, 38] MRF-
sensitive luciferase plasmid was used to determine MRF
transcriptional activity. Additionally, an NFAT-sensitive
luciferase plasmid [39] was co-transfected with a plasmid
encoding NFATc3 [40] to evaluate effects on NFATc3
transcriptional activity. Plasmids encoding WT or K85R
(kinase dead) GSK-3b [41], b-catenin [35], and MyoD [9]
were transfected in combination with the TCF/LEF, TnI, or
4RTK- reporter as indicated. To determine luciferase and
b-galactosidase activity, cells were lysed in luciferase lysis
buffer and stored at -80C. Luciferase (Promega, Madison,
WI) and b-galactosidase (Tropix, Bedford, MA) were
measured according to the manufacturer’s instructions.
Muscle creatine kinase activity
Myogenic differentiation was assessed biochemically via
determination of muscle creatine kinase (MCK) activity.
CellsweregrownonMatrigel-coateddishes.Afterinduction
of differentiation with DM alone or in combination with
LiCl, control-CM, or Wnt-3a for 72 h, cells were washed
twice in cold PBS, lysed in 0.5% Triton X-100, and scraped
from the dish with a rubber policeman (a hand-held ﬂexible
natural-rubber scraper). Lysates were centrifuged for 2 min
at 16,0009g and 4C, and the supernatant was stored in two
aliquots at -80C for determination of protein content or
MCK activity in presence of 1.25% BSA. MCK activity was
measured by using a spectophotometric-based [42] kit from
Stanbio (Stanbio, Boerne, TX). Speciﬁc MCK activity was
calculated after correction for total protein concentration
[43], R
2 values were[0.98 for the standard curve.
May-Grunwald Giemsa staining
C2C12 cells were grown on Matrigel-coated 60-mm dishes
and after induction of differentiation with DM, LiCl, con-
trol-CM or Wnt-3a for 24 or 72 h, cells were washed twice
in PBS (RT), ﬁxed in methanol and stained in May-
Grunwald Giemsa (Sigma, St. Louis, MO) according to the
manufacturer’s instructions. Pictures were taken at 409
and 1009 magniﬁcations using a microscope connected to
a digital camera (DXM 1200F), both from Nikon (Nikon,
Kanagawa, Japan). The 1009 magniﬁed images were taken
in series of four with ﬁxed overlap.
Nuclei count and myogenic index
The total number of nuclei of four or more ﬁelds (1009
magniﬁcation) were counted to determine the number of
nuclei present after 24 and 72 h of differentiation. The
myonuclear distribution was assessed by counting all
nuclei within four 1009 magniﬁed linked images. Counted
nuclei were assigned to one of three classes: single
nucleated myoblasts, dividing or fusing bi-nucleated
myoblasts, or multi-nucleated ([2) myotubes. Per condi-
tion, 800–1,800 nuclei were counted and assigned. Of the
nuclei contained in myotubes, a subdivision was made in
four groups with 3–9, 10–19, 20–29, or [30 nuclei per
myotube.
Western blotting
The C2C12 cells were washed twice with ice-cold 19 PBS
after which they were scraped and lysed in a whole-cell
lysate (WCL) buffer (20 mM Tris, pH 7.4; 150 mM NaCl;
1% Nonidet P-40; 1 mM DTT; 1 mM Na3VO4;1 m M
PMSF; 10 lg/ml Leupeptin and 1% aprotenin) using a
rubber policemen. Next, crude lysates were incubated on
ice for 30 min, followed by a 30-min centrifugation step at
16,0009g and 4C. A portion of the supernatant was saved
for protein determination, prior to the addition with 49
Laemmli sample buffer (0.25 M Tris–HCl pH 6.8; 8% (w/v)
SDS; 40% (v/v) glycerol; 0.4 M DTT, and 0.04% (w/v)
Bromophenol Blue). The samples were boiled for 5 min at
95C and stored at -20C. Total protein concentration was
assessed with the Bio-Rad DC protein assay kit (Bio-Rad,
Hercules, CA) according to the manufacturer’s instruc-
tions. For SDS-PAGE, 0.5–20 lg of protein was loaded per
lane and separated on a Criterion
TM XT Precast 4–12%
Bis–Tris gel (Bio-Rad, #3450124), followed by transfer to
a 0.45-lm Whatman
 Protran
 Nitrocellulose Transfer
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(Bio-Rad Criterion Blotter) (Bio-Rad, Hercules, CA,
USA). The membrane was blocked for 1 h at room tem-
perature in 5% (w/v) NFDM (non-fat dried milk) (ELK,
Campina, the Netherlands) diluted in TBS-Tween-20
(0.05%). Nitrocellulose blots were washed in TBS-Tween-20
(0.05%) on a rotating platform, followed by overnight (o/n)
incubation at 4C with speciﬁc antibodies directed against:
p-GSK-3b (Ser9) (#9336), GSK-3b (#9332), p-Akt
(Ser473) (#9271), Akt (#9272), GAPDH (#2118) (all from
Cell Signaling Technology, Inc., Danvers, MA,) all were
diluted 1/1000 in TBS-Tween-20 (0.05%). After three
washing steps of 10 min each, the blots were probed with a
peroxidase conjugated secondary antibody (Vector Labo-
ratories, #PI-1000), and visualized by chemiluminescence
using Supersignal
 WestPico Chemiluminescent Substrate
(Pierce Biotechnology, Inc.) according to the manufac-
turer’s instructions and exposed to ﬁlm (Biomax light ﬁlm,
Kodak). Western-blot ﬁlms were imaged and quantiﬁed
using the Quantity One analysis software from Bio-Rad.
RNA isolation and assessment of mRNA abundance
by RT-qPCR
C2C12 cells were washed twice with ice-cold 1xPBS after
which Total RNA was isolated using the Totally RNA
TM
kit (Ambion, Austin, TX) according to the manufacturer’s
instructions. After isolation, RNA was dissolved in 1 mM
Na-citrate (pH 6.4) and stored at -80C. The RNA con-
centrations were measured spectrophotometrically using a
Nanodrop
 ND-1000 UV–Vis spectrophotometer. RNA
was diluted[5x in ddH2O and 400 ng of RNA was reverse
transcribed to cDNA using the Transcriptor ﬁrst strand
cDNA synthesis kit (Roche Diagnostics GmbH, Mannheim,
Germany) with anchored oligo-dT primers according to the
manufacturer’s instructions for generating cDNA fragment
of 4 kb with a ﬁnal reaction volume of 20 ll. RNA of
genes of interest (Table 1) were determined by reverse
transcription quantitative PCR (qPCR). qPCR primers were
designed using Primer Express 2.0 software (Applied
Biosystems, Foster City, CA), checked for both primer and
amplicon secondary structures, and than obtained from
Sigma Genosys (Haverhill, UK). qPCR reactions (20-ll
ﬁnal volume) contained absolute qPCR SyBr Green Fluo-
rescein Mix (Abgene, Leusden, NL) and primers (600 nM).
Relative cDNA starting quantities for the samples were
derived by the standard curve method. Standard curve
samples were generated by serial dilution of pooled cDNA
samples and had at least a R
2[0.98 and an efﬁciency
between 90 and 110%. The expression of the genes of
interest were normalized with a correction factor derived
by geNorm, which is based on a combination of the
expression levels of b-actin, cyclophillin A, GAPDH, and
RPL13A. RT-qPCR reactions were performed on a MyiQ
single-color real-time thermal cycler (Bio-Rad, Hercules,
CA).
DNA content determination
After treatment, cells were washed twice with cold PBS.
Then Tris–EDTA buffer was added followed by a freeze–
thaw cycle after which dishes were scraped and the lysate
was collected. DNA content was determined in the cell
lysates using the Quant-iT
TM PicoGreen dsDNA assay kit
(Molecular Probes) according to the manufacturer’s
protocol.
Immunohistochemical staining
C2C12 cells were grown on glass coverslips coated with
Matrigel (BD Biosciences, Bedford, MA) (1:50 in DMEM
low glucose) as described previously [34]. After 72 h of
differentiation, the cells were washed twice with cold PBS
ﬁxed with4%PFA,permeabilized with 0.1%Triton x-100 in
PBS and non-speciﬁc binding was blocked with 1% BSA in
0.1% Triton in PBS. MyHC-fast obtained from Sigma-
Aldrich(St.Louis,MOUSA)wasusedasaprimaryantibody
1:250 in 1% BSA/0.1% Triton/PBS and Alexa ﬂuor 488 goat
anti IgG from Invitrogen was used as a secondary antibody
1:1000 in 1% BSA/0.1% Triton/PBS washed counter stained
with DAPI (20 lg/ml) and mounted with Dako mounting
medium. Pictures were taken at 2009 magniﬁcation using a
ﬂuorescencemicroscopeconnectedtoadigitalcamera(DXM
1200F), both from Nikon (Nikon, Kanagawa, Japan).
Statistical analysis
All values are means ± SEM and raw data was statistically
analyzed for one-way t test with unequal variance. Results
are considered signiﬁcantly different with p\0.05.
Results
Wnt-3a or pharmacological inactivation of GSK-3b
promote myoblast fusion during differentiation
C2C12 myoblasts weredifferentiated inDMwithorwithout
LiCl, or in DM containing diluted medium conditioned
(CM) by Wnt-3a-secreting or control L-cells (Control-CM).
During the ﬁrst 48 h of differentiation, alignment (Supple-
mental Fig. 1), which precedes fusion, appeared to be
enhanced by the presence of Wnt-3a compared to control,
whereas no effects on myoblast survival were observed
(Supplemental Fig. 2). Similar to differentiation with DM,
in control-CM treated myoblasts, myotubes were forming at
526 N. A. M. Pansters et al.72 h. Differentiation in the presence of Wnt-3a markedly
promoted myoblast fusion, resulting in larger myotubes
(Fig. 1a). Pharmacological inhibition of GSK-3b using LiCl
also enhanced myotube formation as reported previously
[8]. Staining for MyHC-fast conﬁrmed that the multinucle-
ated fused cells were genuine myotubes in all conditions
(Supplemental Fig. 3). Myoblast fusion and myotube for-
mation was quantiﬁed by determining the number of nuclei
in each cell. A greater percentage of nuclei residing in
multinucleated cells was observed when myoblasts were
differentiated in presence of LiCl or Wnt-3a compared to
their respective controls (Fig. 1b). In addition, LiCl and
Wnt-3a promoted the formation of larger myotubes con-
taining more nuclei compared to their respective controls
(Fig. 1c). The stimulatory effect of Wnt-3a conditioned
medium on myoblast fusion and myotube formation was
reduced by co-incubation with a Wnt-3a-speciﬁc antibody
(Fig. 1b inset). Transcript levels of genes associated with
proliferation signiﬁcantly decreased compared to GM,
irrespective of treatment conditions (Fig. 1d), indicating
that the observed increase in number of nuclei per myotube
following LiCl or Wnt-3a were not likely the result of pro-
longed myoblast proliferation, which was further supported
by the absence in changes in total nuclei number or total
DNA of adherent cells (Supplemental Fig. 2).
Muscle-speciﬁc gene expression during differentiation
is stimulated by pharmacological inactivation
of GSK-3b but not by Wnt-3a
Next we investigated whether enhanced myotube forma-
tion by Wnt-3a was associated with increased muscle-
speciﬁc gene expression. Muscle creatine kinase (MCK)
activity was increased by LiCl compared with control after
72 h (Fig. 2a), which is in line with previous results [8]. In
contrast, MCK activity was not increased by Wnt-3a when
compared to controls (Fig. 2a). Similarly, mRNA expres-
sion levels of MCK, but also myosin heavy chain (MyHC)-
IIB and MyHC-perinatal at 72 h were only increased by
LiCl, but not by Wnt-3a treatment (Fig. 2b). Differentia-
tion-induced transcriptional activation, of the troponin I
(TnI) promoter, evaluated in a stable reporter cell line, was
increased by LiCl but not Wnt-3a (Fig. 2c) as increasing
concentration of Wnt-3a even slightly decreased TnI-pro-
moter transactivation. In line with this, over-expression of
b-catenin, did not promote TnI-promoter transactivation
(Supplemental Fig. 4A). Next, MRF activity was assessed
with a transiently transfected, MyoD-sensitive (supple-
mental Fig. 4B), 4RTK luciferase reporter. Only LiCl
induced an increase in MRF transcriptional activity com-
pared to control, whereas Wnt-3a did not affect MRF
Table 1 Genes of interest real-
time quantitative PCR primers
Gene name Accession number
(ensemble)
Primers
b-actin ENSMUST00000052678 FW: 50-CTGAATGGCCCAGGTCTGA-30
RV: 50-CCCTCCCAGGGAGACCAA-30
Cyclophilin A ENSMUST00000090749 FW: 50-TTCCTCCTTTCACAGAATTATTCCA-30
RV: 50-CCGCCAGTGCCATTATGG-30
GAPDH ENSMUST00000118875 FW: 50-CAACTCACTCAAGATTGTCAGCAA-30
RV: 50-TGGCAGTGATGGCATGGA-30
RPL13A ENSMUST00000102669 FW: 50-CACTCTGGAGGAGAAACGGAAGG-30
RV: 50-GCAGGCATGAGGCAAACAGTC-30
Cyclin D1 ENSMUST00000093962 FW: 50-CATTCCCTTGACTGCCGAGAAGTT-30
RV: 50-TTGTTCACCAGAAGCAGTT CCATTT-30
PCNA ENSMUST00000028817 FW: 50-CCAAATCAAGAGAAAGTTTCAGACTATGA-30
RV: 50-TCACCCGACGGCATCTTTATT-30
c-Myc ENSMUST00000022971 FW: 50-ACCACCAGCAGCGACTCTGA -30
RV: 50-GCCCGACTCCGACCTCTTG-30
MCK ENSMUST00000003643 FW: 50-AGGTTTTCCGCCGCTTCT-3
RV: 50-CGGTGCCCAGGTTGGA-3
MyHC 2B ENSMUST00000018632 FW: 50-ACAAGCTGCGGGTGAAGAGC-3
RV: 50-CAGGACAGTGACAAAGAACG-3
MyHC peri(natal) ENSMUST00000019625 FW: 50-ACACATCTTGCAGAGGAAGG-3
RV:50- TAAACCCAGAGAGGCAAGTG-3
Axin 2 ENSMUST00000052915 FW: 50-CTCAGCAAAAAGGGAAATTACAGGTAT-30
RV: 50-ACTGTCTCGTCGTCCCAGATCTC-30
GSK-3b and myogenic differentiation 527activity (Fig. 2d), in line with the absence of a stimulatory
effect on muscle-speciﬁc gene expression.
Wnt-3a or pharmacological inhibition of GSK-3b
induce b-catenin stabilization and b-catenin-dependent
transcriptional activity in differentiating myoblasts
To investigate whether Wnt-3a induces Wnt/b-catenin
signaling in C2C12 myoblasts, b-catenin protein abundance
was assessed. A clear increase ([2.5 fold) in cellular
b-catenin protein content was observed following 24 h
differentiation in DM containing 1/10 diluted Wnt-3a-CM
compared to control-CM (Fig. 3a). To assess whether
b-catenin accumulation was accompanied by increases in
its functional activity as a transcriptional co-activator,
b-catenin-dependent TCF/LEF transcriptional activity was
assessed in C2C12 cells stably transfected with a TCF/LEF-
sensitive promoter reporter construct. Wnt-3a induced a
concentration- (Fig. 3b) and time-dependent (Fig. 3c)
increase in TCF/LEF transcriptional activity. Moreover,
Wnt-3a induced TCF/LEF transcriptional activity was
abrogated by co-incubation with a Wnt-3a-speciﬁc, but not
isotype control, antibody (Fig. 3d). In addition to Wnt-3a,
pharmacological inhibition of GSK-3b activity by LiCl
Fig. 1 Wnt-3a or LiCl promote myoblast fusion during differentia-
tion. C2C12 myoblasts were differentiated for a 72 h in control-CM
or Wnt-3a-CM (each diluted 1/10 in DM), or DM in presence or
absence of LiCl (10 mM), ﬁxed and stained with May-Grunwald
Giemsa to determine myoblast fusion and myotube formation or for
24 h to determine mRNA expression. Shown are representative
pictures of [10 independent experiments at 409 and 1009 magni-
ﬁcation. From these pictures (b), myoblast fusion was quantiﬁed by
determining nuclear distribution of 800–1,800 nuclei for each
separate condition, which is expressed as the percent of nuclei
residing in cells containing 1, 2, or [2 nuclei, reﬂecting
mononucleated myoblasts (one nucleus), dividing or fusing myoblasts
(two nuclei) or myotubes ([2 nuclei), respectively shown is
representative data of three independent experiments. b Wnt-3a-CM
was pre-incubated with an anti-Wnt-3a antibody, and cells were
cultured for 120 h and myonuclear distribution was assessed.
c Stratiﬁcation of myonuclear content in myotubes of LiCl or Wnt-
3a-treated cultures. d C2C12 myoblasts were differentiated for 24 h
and RNA was extracted for assessment of proliferation-associated
mRNA transcripts shown are (c, d) representative data of three
independent experiments (n = 3 ± SEM), *p\0.01, and NS non-
signiﬁcant
528 N. A. M. Pansters et al.also induced TCF/LEF transcriptional activity (Fig. 3d).
Finally, to assess endogenous b-catenin mediated gene
expression, Axin 2 mRNA levels were assessed. Axin 2
mRNA expression was increased by LiCl ([2.5 fold) and
Wnt-3a ([14 fold) compared with their respective controls
(Fig. 3e).
GSK-3b activity directly inhibits b-catenin-dependent
TCF/LEF transcriptional activity
To address GSK-3b regulation of b-catenin-dependent
transcriptional activity in skeletal muscle cells, C2C12
myoblasts were transiently transfected with a TCF/LEF
responsive promoter luciferase reporter plasmid. Simulta-
neous over-expression of b-catenin resulted in increased
TCF/LEF transcriptional activity (Fig. 4). In contrast, over-
expression of wild-type (WT-)GSK-3b led to suppressed
b-catenin-induced TCF/LEF transcriptional activity
(Fig. 4), whereas over-expression of a dominant negative
(dn-)GSK-3b (K85R) mutant actually enhanced b-catenin-
dependent transcriptional activity (Fig. 4). Therefore,
inhibition of b-catenin-mediated transcriptional activation
requires enzymatically active GSK-3b.
Wnt-3a and IGF-I regulate distinct GSK-3b substrates
in differentiating myoblasts
In contrast to Wnt-3a, inactivation of GSK-3b by IGF-I did
not result in b-catenin accumulation after 24 h (Fig. 5a), or
affect b-catenin-dependent transcriptional activity after
incubation 24 h (Fig. 5b), 48, 96, or 120 h of incubation
(data not shown). GSK-3b inactivation following IGF-I
signaling results from phosphorylation GSK-3b at Ser-9
[44]. GSK-3b phosphorylation was increased by IGF-I
(Fig. 5c), while no effect was observed in response to Wnt-3a.
Similar results were seen for Akt phosphorylation
(Supplemental Fig. 5). This indicates that Wnt/b-catenin
signaling in skeletal muscle cells is not dependent on
GSK-3b phosphorylation at Ser-9, which is in line with
previous reports [45, 46]. Increased muscle-speciﬁc gene
expression in response to genetic or pharmacological
GSK-3b inhibition was previously shown to be mediated
by the GSK-3b phospho-substrate and transcription factor
Fig. 2 Muscle-speciﬁc gene expression during differentiation is
stimulated by LiCl but not by Wnt-3a. C2C12 myoblast cells were
cultured in DM with or without LiCl (10 mM), control, or Wnt-3a
CM (diluted 1/10, or as indicated, in DM). a After 72 h, lysates were
prepared for determination of muscle creatine kinase activity and total
protein. Results are expressed as speciﬁc enzyme activity (units/mg
protein). b After 72 h, lysates were prepared to determine mRNA
expression levels of MCK, MyHC IIB, and perinatal. c Myoblasts
containing a stable genomically integrated troponin I (TnI) luciferase
reporter construct were cultured for 48 h in DM, ±LiCl (10 mM), or
Wnt-3a or control-CM (1/10 diluted in DM). Alternatively,
(d) C2C12 myoblasts were transfected with a 4RTK luciferase-
reporter construct and plasmid encoding b-gal (0.25lg each) and
cultured in DM with or without LiCl (10 mM), control, or Wnt-3a
CM (diluted 1/10 in DM). Lysates were prepared for luciferase and
b-galactosidase enzyme activity (RLU/mg protein) or (RLU lucifer-
ase/b-gal activity). Shown are representative graphs of three
independent experiments (n = 3 ± SEM), *p\0.05,
#p\0.01,
$p\0.001, and NS non-signiﬁcant
c
GSK-3b and myogenic differentiation 529NFATc3 [9]. Evaluation of NFATc3 transcriptional activity
using a transiently transfected NFAT luciferase reporter
construct revealed increased NFAT-dependent transcription
following either IGF-I or LiCl, but not in response to
Wnt-3a or over-expression of b-catenin (Fig. 5d).
Discussion
Recent work identiﬁed GSK-3b as a negative regulator of
myogenic differentiation controlled by IGF-I signaling [8].
Wnt/b-catenin signaling also involves regulation of
GSK-3b, and is reported to participate in the initiation of
pre-myogenic cell differentiation [47]. Besides its well-
established role in skeletal muscle formation during
embryogenesis [23], recent studies propose the involvement
of Wnt/b-catenin signaling in postnatal skeletal muscle
hypertrophy [48, 49]. However, whether Wnt/b-catenin
signaling affects myogenic differentiation during skeletal
muscle growth was not assessed in these studies. Our results
reveal a potential role for Wnt/b-catenin signaling in myo-
genic differentiation, as Wnt-3a induced a marked increase
in C2C12 myoblast fusion and myotube formation during
differentiation. This is in line with ﬁndings describing
stimulation of myotube formation by co-culture of myo-
blasts on Wnt1-presenting monolayers [50]. In our study,
however, myoblasts were provided with cell-free condi-
tioned medium from Wnt-3a-secreting L-cells to rule out
producer-cell-myoblast interaction effects. To conﬁrm that
stimulation of fusion (Fig. 1b inset) and TCF/LEF tran-
scriptional activity (Fig. 3e) was attributable to Wnt-3a, the
conditioned medium was incubated with a Wnt-3a-speciﬁc
Fig. 3 Wnt-3a or LiCl induce
b-catenin stabilization and
b-catenin-dependent
transcriptional activity in
differentiating myoblasts.
C2C12 myoblasts were
differentiated for a 24 h in
control or Wnt-3a CM (each
diluted 1/10 in DM), lysates
were prepared and cellular
b-catenin and GAPDH protein
content were visualized and
quantiﬁed. Myoblasts
containing a stable genomically
integrated TCF/LEF luciferase
reporter construct were cultured
for b 24 h in DM, Wnt-3a CM
diluted as indicated, or c or for
the indicated time in control or
Wnt-3a CM diluted 1/10 in DM.
C2C12 myoblasts were cultured
for d 24 h in DM with or
without LiCl (10 mM), control
or Wnt-3a CM (pre-incubated
with a Wnt-3a-speciﬁc or
isotype control antibody for 1 h
at 37C) diluted 1/10 in DM.
After the indicated times, the
lysates were prepared for
speciﬁc enzyme activity
(RLU/mg protein). Myoblast
were e harvested 24 h after
induction of differentiation for
determination of endogenous
Axin 2 mRNA levels. Shown
are representative graphs of
three independent experiments
(n = 3 ± SEM), *p\0.05,
#p\0.01,
$p\0.001, and NS
non-signiﬁcant
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Finally, opposed to the study by Rochat et al., we did not
supplement our cells with insulin, as one of our aims was to
distinguishbetweeneffectsofGSK-3binhibitionbyWnt-3a
and IGF-I/insulin signaling.
Improvement of myoblast fusion by Wnt-3a, reﬂected
by an increased myogenic index, was similar to stimula-
tion of fusion following GSK-3b inhibition by LiCl [8].
Although Wnt-3a can induce expression of genes pro-
moting proliferation like Cyclin-D1 and c-myc [51, 52],
the increased myogenic index did not result from sus-
tained cell division, as the decrease in proliferation
marker mRNA levels (two-fold or more) following
induction of differentiation was not affected by Wnt-3a or
LiCl. Alternatively, improved myoblast survival could
contribute to an increased myogenic index, as inhibition
of GSK-3b reduces caspase activity and cellular apoptosis
[53]. Determination of DNA content and total nuclear
count of the adherent cells 24–48 h after induction of
differentiation revealed no changes in the presence of
either LiCl or Wnt-3a. This leads to the observation that
the increased myogenic index did not result from either
increased proliferation or survival of myoblasts, but is
likely attributable to improved cell–cell interactions and
subsequent myoblast alignment. Following the improved
alignment, larger myotubes after Wnt-3a or LiCl stimu-
lation are observed, which could result from either faster
or enhanced myoblast-myoblast, myoblast-myotube, or
myotube-myotube fusion [54, 55]. We can, however, not
discern at present which of these processes results in those
larger myotubes. Although they are already observed
3 days after induction of differentiation.
Wnt-3a as well as LiCl-induced GSK-3 inactivation
stabilized and increased cellular levels of b-catenin leading
to b-catenin-dependent TCF/LEF transcriptional activity in
differentiating myoblasts, which is in agreement with
previous reports [11, 56, 57]. In addition, over-expression
of WT-GSK-3b in myoblasts conﬁrmed direct inhibition of
b-catenin-induced TCF/LEF transcriptional activity by
GSK-3b. Conversely, inhibition of endogenous GSK-3
activity or over-expression of dominant-negative (dn)-
GSK-3b (K85R) increased TCF/LEF reporter activity, the
latter likely resulting from competition with endogenous
GSK-3 for participation in the degradation-complex to
phosphorylate b-catenin [58, 59].
GSK-3b inactivation by IGF-I [8] or LiCl (shown here)
resulted in increased muscle-speciﬁc gene expression dur-
ing differentiation, such as increased MCK and MyHC
mRNA expression, and TnI-promoter activity. Wnt-3a-
mediated GSK-3 inactivation stimulated myoblast fusion,
which coincided with increased b-catenin-dependent tran-
scriptional activity. Wnt/b-catenin signaling is shown to
precede MRF expression, which controls myogenic dif-
ferentiation [5, 26, 60], and some reports suggest Wnt
signaling may increase MyoD expression [61, 62]. There-
fore, we expected Wnt-3a to increase muscle-speciﬁc gene
expression. To our surprise however, Wnt-3a-mediated
GSK-3 inactivation did not increase muscle-speciﬁc pro-
tein abundance or mRNA transcripts, muscle-speciﬁc
promoter transactivation or MRF transcriptional activity.
The latter results appear to be in contrast to postulated
effects of Wnt signaling on MRF expression. However,
very different experimental settings were used to obtain
these results, including over-expression of Wnt ligands in
combination with other stimulatory factors. Nevertheless,
as any biologically signiﬁcant effects on MRF expression
should result in altered MRF activity, we are conﬁdent Wnt
does not alter MRF functionally in differentiating myo-
blasts, as MRF-dependent transcriptional activity was not
altered in presence of Wnt-3a. Previously, increased mus-
cle-speciﬁc gene expression following GSK-3b inhibition
was shown to involve increased NFATc3 transcriptional
activity [9]. In line with the absence of a stimulatory effect
on muscle-speciﬁc gene expression and in contrast to IGF-I
or LiCl, Wnt-3a did not induce NFATc3 transcriptional
activity. Furthermore, b-catenin over-expression did not
affect NFATc3 transcriptional or TnI-promoter activity.
Overall, these data indicate that stimulation of muscle-
speciﬁc gene expression corresponds with increased tran-
scriptional activity of IGF-I but not Wnt-3a signaling
associated GSK-3b phospho-substrates.
In contrast to our ﬁndings, increased MyHC-IIB mRNA
expression by IGF-I was reported to in part depend on
nuclear b-catenin accumulation [63]. However, the
*seven-fold lower IGF-I concentrations used in our
Fig. 4 GSK-3b activity directly inhibits b-catenin-dependent TCF/
LEF transcriptional activity. C2C12 myoblasts were transiently
transfected with a TCF/LEF luciferase reporter plasmid and plasmids
encoding b-gal (0.25 lg each), b-catenin (0.5 lg), WT or kinase dead
(K85R)-GSK-3b (1.0 lg each). After 24 h incubation in DM with or
without LiCl (5 mM), cells were lysed to measure luciferase and
b-gal activity. Shown is a representative graph of three independent
experiments (n = 3 ± SEM), *p\0.05,
#p\0.01,
$p\0.001, and
NS non-signiﬁcant
GSK-3b and myogenic differentiation 531studies did not affect b-catenin protein content or b-catenin
transcriptional activity (Fig. 5a, b), despite a robust
increase in GSK-3b phosphorylation (Fig. 5c) or muscle-
speciﬁc gene expression [8] in differentiating myoblasts.
Based on this, we postulate that b-catenin presence may aid
IGF-I stimulated MyHC-IIB promoter activity [63], but
that stabilization of b-catenin is not sufﬁcient to induce
muscle-speciﬁc gene expression.
Nevertheless, most literature suggests that GSK-3b
inactivation by IGF-I/Akt signaling is not sufﬁcient to sta-
bilize b-cateninorinduceb-catenin-dependent transcription
[18, 45, 46, 64]. The inability of IGF-I to affect the GSK-3b
substrate b-catenin transcriptional activity likely relates to
the unique signaling route by which Wnt inactivates GSK-3,
i.e., via its sequestration by Axin [46, 57, 65]. Moreover,
Wnt-mediated GSK-3 inactivation is not dependent on the
Akt phosphorylation sites of GSK-3 [45, 66]. In agreement
withthis,Wnt-3adidnotinduceGSK-3bphosphorylationin
differentiating myoblasts, nor did it affect NFATc3 tran-
scriptional activity, as opposed to IGF-I mediated GSK-3b
inactivation. These data support the notion that the differ-
ential inactivation of GSK-3b by IGF-I and Wnt/b-catenin
signaling constitutes the molecular basis to differentiate
between GSK-3b substrates [46, 64].
Fig. 5 Wnt-3a and IGF-I regulate distinct GSK-3b substrates in
differentiating myoblasts. C2C12 myoblasts were differentiated for
a 24 h in DM with or without IGF-I (5nM) or LiCl (10 mM), control,
or Wnt-3a CM (each diluted 1/10 in DM), lysates were prepared and
cellular b-catenin, and GAPDH protein content were visualized and
quantiﬁed. Alternatively, b myoblasts containing a stable genomically
integrated TCF/LEF luciferase reporter construct were cultured for
24 h under the same conditions. c C2C12 myoblasts were treated for
2 h in DM with IGF (5nM) or LiCl (10 mM), or 2 h incubated in
control or Wnt-3a CM (each diluted 1/10 in DM). Lysates were
prepared and cellular phospho-GSK-3b and total GSK-3b protein
content were visualized and quantiﬁed. d C2C12 myoblasts were
transfected with a NFAT-sensitive promoter-luciferase reporter
plasmid and plasmids encoding b-gal (0.25 lg each), NFATc3
(1.0 lg each) b-catenin, or empty vector (1.0 lg each) and treated
as indicated. After 48 h incubation, the cells were lysed to measure
luciferase and b-galactosidase activity. Shown are representative
graphs of three independent experiments (n = 3 ± SEM), *p\0.05,
#p\0.01,
$p\0.001, and NS non-signiﬁcant
532 N. A. M. Pansters et al.Duringmyogenicdifferentiation,b-catenin,andNFATc3
may represent the GSK-3 substrates subject to independent
regulationbythedistinctGSK-3signalingpools,andmaybe
responsible for the separate stimulation of myoblast fusion
and muscle-speciﬁc gene expression by Wnt-3a and IGF-I,
respectively. In line with this, LiCl, which inhibits GSK-3
enzymatic activity towards both b-catenin and NFAT-c3,
promoted both myoblast fusion and myogenic gene
expression. Although the segregation of these aspects of
myogenic differentiation has been reported previously
[67, 68], this is the ﬁrst report to imply the dissociation of
myoblast fusion and gene expression may be controlled by
these distinct modes of GSK-3b inactivation.
The observed effect of Wnt-3a on increased myoblast
fusion may relate to the function of b-catenin as an
essential binding partner for the cytoplasmic tail of various
cadherins, including M-cadherin [69]. b-catenin co-localizes
with M-cadherin at the cell–cell contact sites in membranes
and is essential for proper fusing of myoblasts [70–72].
Therefore, increased myoblast fusion observed in response
to Wnt-3a or LiCl inactivation of GSK-3 may rather relate
to the function of b-catenin in cell–cell contact than its
activity as a transcriptional co-regulator. This idea is sup-
ported by the observation that LiCl caused a less potent
induction of TCF/LEF transcriptional activation or Axin-2
expression compared to 1/10 diluted Wnt-3a, despite sim-
ilar effects on myoblast fusion, thereby demonstrating that
the effects of b-catenin activity modulation do not linearly
correlate with b-catenin-dependent transcriptional activity.
In conclusion, our results demonstrate that Wnt-3a indu-
ces b-catenin signaling in differentiating myoblasts, which
can be mimicked by pharmacological, but not IGF-I-depen-
dentGSK-3inhibition.Moreover,Wnt-3astronglypromotes
myoblast fusion and myotube formation without enhancing
muscle-speciﬁc gene expression. These data demonstrate
that two distinct signaling routes controlling GSK-3 activity
independently regulate myoblast fusion and muscle-speciﬁc
gene expression during myogenic differentiation.
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